James Shaughnessy Sells 12,000 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) insider James Shaughnessy sold 12,000 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $46.83, for a total transaction of $561,960.00. Following the completion of the transaction, the insider directly owned 53,631 shares in the company, valued at $2,511,539.73. This trade represents a 18.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Price Performance

DOCU opened at $48.37 on Friday. The company has a market cap of $9.40 billion, a price-to-earnings ratio of 32.68, a price-to-earnings-growth ratio of 1.88 and a beta of 0.99. The firm has a 50 day simple moving average of $47.40 and a 200 day simple moving average of $61.85. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $94.67.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The firm had revenue of $836.86 million for the quarter, compared to analysts’ expectations of $828.23 million. During the same period last year, the firm earned $0.86 earnings per share. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. As a group, analysts expect that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its board has authorized a share buyback plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 21% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Centaurus Financial Inc. grew its stake in Docusign by 2.6% in the second quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares during the period. Mitchell & Pahl Private Wealth LLC lifted its holdings in shares of Docusign by 0.7% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock valued at $1,544,000 after purchasing an additional 149 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Docusign by 15.1% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock valued at $89,000 after purchasing an additional 161 shares in the last quarter. Smartleaf Asset Management LLC grew its position in shares of Docusign by 8.2% in the 2nd quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock valued at $166,000 after purchasing an additional 165 shares during the period. Finally, Americana Partners LLC grew its position in shares of Docusign by 3.3% in the 3rd quarter. Americana Partners LLC now owns 5,467 shares of the company’s stock valued at $394,000 after purchasing an additional 176 shares during the period. 77.64% of the stock is currently owned by institutional investors.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
• Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
• Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
• Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
• Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
• Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
• Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

Wall Street Analyst Weigh In

DOCU has been the subject of a number of recent analyst reports. Jefferies Financial Group downgraded Docusign from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $45.00 in a report on Monday, February 23rd. HSBC set a $53.00 target price on Docusign in a research report on Friday, February 13th. Wells Fargo & Company lowered their price target on Docusign from $75.00 to $60.00 and set an “equal weight” rating for the company in a research note on Wednesday, March 18th. Evercore cut their price target on shares of Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a research report on Friday, December 5th. Finally, Morgan Stanley reduced their price objective on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 18th. Five research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $64.67.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.